Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Professor Jacqui Matthews joins Austin Davis Biologics
Professor Jacqui Matthews.

She will take on the role of director of veterinary science.

Professor Jacqui Matthews has been appointed as director of veterinary science for Austin Davis Biologics (ADB), beginning on 14 November 2022.

The company deals in veterinary diagnostics and parasitology research, particularly in equine health. 

In her capacity as director of veterinary science, Professor Matthews will lead research and development activities, and will provide advice and support to clients who use the diagnostic test services through the use of webinars and training activities.

Dr Corrine Austin, founder and managing director of ABD, welcomed Professor Matthews to the team: “We are thrilled that Professor Matthews is joining our family-run veterinary diagnostic company. 

“Her input to ADB’s research programmes, as well as the wider equine parasitology field, is highly valued.”

After originally qualifying as a veterinary surgeon, Professor Matthews moved into the field of academia, and for 25 years has become renowned for her work in equine parasitology.

Professor Matthews is the inventor of the small redworm blood test, and has published over 140 peer-reviewed papers.

Discussing her new position, Professor Matthews said: “I am absolutely delighted to be joining ADB and given this opportunity to support and promote evidence based helminth control in horses in the UK and overseas. 

“I am also really looking forward to bringing more innovative diagnostics to the market to support animal health”.

Dr Austin added: “Not only do we have a busy future research program, but we hold a lot of information that hasn’t yet been published; Jacqui’s new position within ADB will accelerate future research as well dissemination of our existing research data.”

 

Image (C) Austin Davis Biologics

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.